JPMorgan Hikes IREN Target to $46, Stays Underweight
JPMorgan raises its IREN price target to $46 but preserves an underweight stance, citing structural risk in NVIDIA’s ...
This brief overview contrasts lifecycle funds with target date funds, highlighting key distinctions to help you choose the right fund for retirement planning.
18,690 articlesJPMorgan raises its IREN price target to $46 but preserves an underweight stance, citing structural risk in NVIDIA’s ...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Walmart and Target reported diverging strategies as they chase the same shopper. Walmart leans on scale, ads, and a b...
China unveils a restrained 2026 growth target of 4.5% to 5%, marking the lowest goal in decades as policymakers weigh...
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
Money conversations can feel tricky for two. In this second installment of the couple’s guide money series, you’ll le...
Markets can swing wildly, but your plan shouldn’t. This guide shows how to prepare for a stock market crash coming wi...
Tiny margins decide outcomes in sports and money alike. This article translates a razor-thin finish into practical pe...
Public life aside, money stress nearly derailed a famous romance. This insight shows how a tense breakup can reveal t...
With Broadcom set to report earnings, investors are weighing momentum in AI infrastructure against valuation. This gu...
SpaceX IPO buzz is electric. Here are the two simplest routes retail investors can use to access shares at the IPO pr...